Mechanisms of Tumor Necrosis Factor α Antagonist–Induced Lupus in a Murine Model

E-ISSN： 2326-5205|67|1|225-237

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.1, 2015-01, pp. : 225-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour necrosis factor antagonist‐induced lupus: a Critically Appraised Topic

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1519-1526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long persistence of tumour necrosis factor‐α antagonist‐induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects: a case study of 14 patients with psoriasis

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e9-e10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brain‐derived neurotrophic factor prevents the endothelial barrier dysfunction induced by interleukin‐1β and tumor necrosis factor‐α

JOURNAL OF PERIODONTAL RESEARCH, Vol. 50, Iss. 4, 2015-08 ,pp. : 444-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor Necrosis Factor α Is Necessary for Granulocyte-Macrophage-Colony-Stimulating-Factor-Induced Eosinophil Transendothelial Migration

International Archives of Allergy and Immunology, Vol. 115, Iss. 1, 1997-12 ,pp. : 24-32

Karger

Access to resources Recommend Favorite

Cost Effectiveness of Interferon-Gamma Release Assay for Tuberculosis Screening of Rheumatoid Arthritis Patients prior to Initiation of Tumor Necrosis Factor-α Antagonist Therapy

By Kowada Akiko

Molecular Diagnosis & Therapy, Vol. 14, Iss. 6, 2010-12 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite